157 related articles for article (PubMed ID: 14610231)
1. L-NAME (N omega-nitro-L-arginine methyl ester), a nitric-oxide synthase inhibitor, and WIN 55212-2 [4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one], a cannabinoid agonist, interact to evoke synergistic hypothermia.
Rawls SM; Tallarida RJ; Gray AM; Geller EB; Adler MW
J Pharmacol Exp Ther; 2004 Feb; 308(2):780-6. PubMed ID: 14610231
[TBL] [Abstract][Full Text] [Related]
2. N-methyl-D-aspartate antagonists and WIN 55212-2 [4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1-i,j]quinolin-6-one], a cannabinoid agonist, interact to produce synergistic hypothermia.
Rawls SM; Cowan A; Tallarida RJ; Geller EB; Adler MW
J Pharmacol Exp Ther; 2002 Oct; 303(1):395-402. PubMed ID: 12235276
[TBL] [Abstract][Full Text] [Related]
3. CB1 receptors in the preoptic anterior hypothalamus regulate WIN 55212-2 [(4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one]-induced hypothermia.
Rawls SM; Cabassa J; Geller EB; Adler MW
J Pharmacol Exp Ther; 2002 Jun; 301(3):963-8. PubMed ID: 12023525
[TBL] [Abstract][Full Text] [Related]
4. A role of nitric oxide in WIN 55,212-2 tolerance in mice.
Spina E; Trovati A; Parolaro D; Giagnoni G
Eur J Pharmacol; 1998 Feb; 343(2-3):157-63. PubMed ID: 9570463
[TBL] [Abstract][Full Text] [Related]
5. GABAA receptors modulate cannabinoid-evoked hypothermia.
Rawls SM; Tallarida RJ; Kon DA; Geller EB; Adler MW
Pharmacol Biochem Behav; 2004 May; 78(1):83-91. PubMed ID: 15159137
[TBL] [Abstract][Full Text] [Related]
6. A novel role of cannabinoids: implication in the fever induced by bacterial lipopolysaccharide.
Benamar K; Yondorf M; Meissler JJ; Geller EB; Tallarida RJ; Eisenstein TK; Adler MW
J Pharmacol Exp Ther; 2007 Mar; 320(3):1127-33. PubMed ID: 17194800
[TBL] [Abstract][Full Text] [Related]
7. Capsaicin and nitric oxide synthase inhibitor interact to evoke a hypothermic synergy.
Ding Z; Cowan A; Tallarida R; Rawls SM
Neurosci Lett; 2006 Nov; 409(1):41-6. PubMed ID: 17018247
[TBL] [Abstract][Full Text] [Related]
8. Effects of cannabinoids on non-adrenergic non-cholinergic-mediated relaxation in guinea-pig trachea.
Nieri P; Martinotti E; Testai L; Martinelli C; Breschi MC
Eur J Pharmacol; 2003 Aug; 475(1-3):115-8. PubMed ID: 12954367
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of cannabinoid protection from neuronal excitotoxicity.
Kim SH; Won SJ; Mao XO; Jin K; Greenberg DA
Mol Pharmacol; 2006 Mar; 69(3):691-6. PubMed ID: 16299067
[TBL] [Abstract][Full Text] [Related]
10. Agmatine and a cannabinoid agonist, WIN 55212-2, interact to produce a hypothermic synergy.
Rawls SM; Tallarida RJ; Zisk J
Eur J Pharmacol; 2006 Dec; 553(1-3):89-98. PubMed ID: 17109846
[TBL] [Abstract][Full Text] [Related]
11. Differences in the relative potency of SR 141716A and AM 251 as antagonists of various in vivo effects of cannabinoid agonists in C57BL/6J mice.
McMahon LR; Koek W
Eur J Pharmacol; 2007 Aug; 569(1-2):70-6. PubMed ID: 17553486
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid regulation of nitric oxide synthase I (nNOS) in neuronal cells.
Carney ST; Lloyd ML; MacKinnon SE; Newton DC; Jones JD; Howlett AC; Norford DC
J Neuroimmune Pharmacol; 2009 Sep; 4(3):338-49. PubMed ID: 19365734
[TBL] [Abstract][Full Text] [Related]
13. Physiological evidence for interaction between the HIV-1 co-receptor CXCR4 and the cannabinoid system in the brain.
Benamar K; Yondorf M; Geller EB; Eisenstein TK; Adler MW
Br J Pharmacol; 2009 Aug; 157(7):1225-31. PubMed ID: 19558543
[TBL] [Abstract][Full Text] [Related]
14. [Effects of central and peripheral administration of a nitric oxide synthase inhibitor on AVP-induced hypothermia in rats].
Yang YL; Yang Z; Li XM; Li YS; Luo XH
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2003 Aug; 19(3):261-4. PubMed ID: 21189593
[TBL] [Abstract][Full Text] [Related]
15. Diuretic effects of cannabinoids.
Paronis CA; Thakur GA; Bajaj S; Nikas SP; Vemuri VK; Makriyannis A; Bergman J
J Pharmacol Exp Ther; 2013 Jan; 344(1):8-14. PubMed ID: 23019138
[TBL] [Abstract][Full Text] [Related]
16. R-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)-pyrrolo-[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphtalenylmethanone (WIN-2) ameliorates experimental autoimmune encephalomyelitis and induces encephalitogenic T cell apoptosis: partial involvement of the CB(2) receptor.
Sánchez AJ; González-Pérez P; Galve-Roperh I; García-Merino A
Biochem Pharmacol; 2006 Dec; 72(12):1697-706. PubMed ID: 17007821
[TBL] [Abstract][Full Text] [Related]
17. Effect of chronic administration of R-(+)-[2,3-Dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55,212-2) or delta(9)-tetrahydrocannabinol on cannabinoid receptor adaptation in mice.
Sim-Selley LJ; Martin BR
J Pharmacol Exp Ther; 2002 Oct; 303(1):36-44. PubMed ID: 12235230
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid-induced increase in relapse-like drinking is prevented by the blockade of the glycine-binding site of N-methyl-D-aspartate receptors.
Alén F; Santos A; Moreno-Sanz G; González-Cuevas G; Giné E; Franco-Ruiz L; Navarro M; López-Moreno JA
Neuroscience; 2009 Jan; 158(2):465-73. PubMed ID: 18977415
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid and nitric oxide signaling interplay in the modulation of hippocampal hyperexcitability: Study on electrophysiological and behavioral models of temporal lobe epilepsy in the rat.
Carletti F; Gambino G; Rizzo V; Ferraro G; Sardo P
Neuroscience; 2015 Sep; 303():149-59. PubMed ID: 26135674
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of rostral ventrolateral medulla neuronal nitric-oxide synthase-nitric-oxide signaling mediates the central cannabinoid receptor 1-evoked pressor response in conscious rats.
Ibrahim BM; Abdel-Rahman AA
J Pharmacol Exp Ther; 2012 Jun; 341(3):579-86. PubMed ID: 22366659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]